Serum miR-33a is associated with steatosis and inflammation in patients with non-alcoholic fatty liver disease after liver transplantation.

Serum miR-33a is associated with steatosis and inflammation in patients with non-alcoholic fatty liver disease after liver transplantation.

BACKGROUND & AIMS:MiR-33a has emerged as a critical regulator of lipid homeostasis in the liver. Genetic deficiency of miR-33a aggravates liver steatosis in a preclinical model of non-alcoholic fatty liver disease (NAFLD), and relative expression of miR-33a is increased in the livers of patients...

Full description

Bibliographic Details
Main Authors: Denisa Erhartova, Monika Cahova, Helena Dankova, Marie Heczkova, Irena Mikova, Eva Sticova, Julius Spicak, Ondrej Seda, Pavel Trunecka
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0224820

Internet

https://doi.org/10.1371/journal.pone.0224820

Similar Items